img

Global and India Antipyretic and Analgesic Drugs Market Report & Forecast 2024-2034


Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global and India Antipyretic and Analgesic Drugs Market Report & Forecast 2024-2034

Market Analysis and InsightsGlobal and India Antipyretic and Analgesic Drugs Market
This report focuses on global and India Antipyretic and Analgesic Drugs market, also covers the segmentation data of other regions in regional level and county level.
The global Antipyretic and Analgesic Drugs revenue was US$ million in 2024 and is forecast to a readjusted size of US$ million by 2034 with a CAGR of % during the forecast period (2024-2034).
In India the Antipyretic and Analgesic Drugs revenue is expected to grow from US$ million in 2024 to US$ million by 2034, at a CAGR of % during the forecast period (2024-2034).
The global key players of Antipyretic and Analgesic Drugs include Mallinckrodt, SKPL, Pfizer, Sanofi, Bayer, China National Medicines Guorui Pharmaceutical, Baotai Pharmaceutical, Huaan Pharmaceutical and Yuanhe Pharmaceutical, etc. The global five biggest players hold a share of % in 2024.
Global Antipyretic and Analgesic Drugs Scope and Market Size
Antipyretic and Analgesic Drugs market is segmented in regional and country, by players, by type and by application. Companies, stakeholders, and other participants in the global Antipyretic and Analgesic Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by type and by application for the period 2018-2034.
For India market, this report focuses on the Antipyretic and Analgesic Drugs market size by players, by Type and by Application, for the period 2018-2034. The key players include the global and local players, which play important roles in India.



By Company


Mallinckrodt
SKPL
Pfizer
Sanofi
Bayer
China National Medicines Guorui Pharmaceutical
Baotai Pharmaceutical
Huaan Pharmaceutical
Yuanhe Pharmaceutical
Heping Pharmaceutical
Hongxing Pharmaceutical
Xinhui Pharmaceutical
Dingchang Pharmaceutical
Topfond Pharmaceutical
Taile Pharmaceutical
Kys Pharm
China Resources Double-Crane Pharmaceutical
Segment by Type
Ibuprofen
Paracetamol
Analgin
Naproxen
Aspirin
Others

Segment by Application


Hospital
Clinic
By Region
Americas
United States
Canada
Mexico
Brazil
China
APAC (excluding China)
Japan
South Korea
China Taiwan
ASEAN
India
EMEA
Europe
Middle East
Africa

Chapter Introduction


Chapter 1Introduces Antipyretic and Analgesic Drugs definition, global sales (volume and revenue), India market size, India percentage in global market. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 2Provides the analysis of various market segments by type, covering the volume, price, revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3Provides the analysis of various market segments by application, covering the revenue, price, volume, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4Detailed analysis of Antipyretic and Analgesic Drugs companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Revenue and volume of Antipyretic and Analgesic Drugs in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 6Americas by type, by application and by country, sales, and revenue for each segment.
Chapter 7EMEA by type, by application and by region, sales, and revenue for each segment.
Chapter 8China by type, by application, sales, and revenue for each segment.
Chapter 9APAC (excluding China) by type, by application and by region, sales, and revenue for each segment.
Chapter 10Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Antipyretic and Analgesic Drugs sales, revenue, gross margin, and recent development, etc.
Chapter 11Analysis of industrial chain, sales channel, key raw materials, distributors, and customers.
Chapter 12Research findings and conclusion

Table of Content

1 Study Coverage
1.1 Antipyretic and Analgesic Drugs Product Introduction
1.2 Global Antipyretic and Analgesic Drugs Outlook 2018 VS 2024 VS 2034
1.2.1 Global Antipyretic and Analgesic Drugs Sales in US$ Million for the Year 2018-2034
1.2.2 Global Antipyretic and Analgesic Drugs Sales in Volume for the Year 2018-2034
1.3 India Antipyretic and Analgesic Drugs Outlook 2018 VS 2024 VS 2034
1.3.1 India Antipyretic and Analgesic Drugs Sales in US$ Million for the Year 2018-2034
1.3.2 India Antipyretic and Analgesic Drugs Sales in Volume for the Year 2018-2034
1.4 Antipyretic and Analgesic Drugs Market Size, India VS Global, 2018 VS 2024 VS 2034
1.4.1 The Market Share of India Antipyretic and Analgesic Drugs in Global, 2018 VS 2024 VS 2034
1.4.2 The Growth Rate of Antipyretic and Analgesic Drugs Market Size, India VS Global, 2018 VS 2024 VS 2034
1.5 Antipyretic and Analgesic Drugs Market Dynamics
1.5.1 Antipyretic and Analgesic Drugs Industry Trends
1.5.2 Antipyretic and Analgesic Drugs Market Drivers
1.5.3 Antipyretic and Analgesic Drugs Market Challenges
1.5.4 Antipyretic and Analgesic Drugs Market Restraints
1.6 Study Objectives
1.7 Years Considered
1.8 Years Considered
2 Antipyretic and Analgesic Drugs by Type
2.1 Antipyretic and Analgesic Drugs Market Segment by Type
2.1.1 Ibuprofen
2.1.2 Paracetamol
2.1.3 Analgin
2.1.4 Naproxen
2.1.5 Aspirin
2.1.6 Others
2.2 Global Antipyretic and Analgesic Drugs Market Size by Type
2.2.1 Global Antipyretic and Analgesic Drugs Sales in Value, by Type (2018, 2024 & 2034)
2.2.2 Global Antipyretic and Analgesic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
2.2.3 Global Antipyretic and Analgesic Drugs Average Selling Price (ASP) by Type (2018, 2024 & 2034)
2.3 India Antipyretic and Analgesic Drugs Market Size by Type
2.3.1 India Antipyretic and Analgesic Drugs Sales in Value, by Type (2018, 2024 & 2034)
2.3.2 India Antipyretic and Analgesic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
2.3.3 India Antipyretic and Analgesic Drugs Average Selling Price (ASP) by Type (2018, 2024 & 2034)
3 Antipyretic and Analgesic Drugs by Application
3.1 Antipyretic and Analgesic Drugs Market Segment by Application
3.1.1 Hospital
3.1.2 Clinic
3.2 Global Antipyretic and Analgesic Drugs Market Size by Application
3.2.1 Global Antipyretic and Analgesic Drugs Sales in Value, by Application (2018, 2024 & 2034)
3.2.2 Global Antipyretic and Analgesic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 Global Antipyretic and Analgesic Drugs Average Selling Price (ASP) by Application (2018, 2024 & 2034)
3.3 India Antipyretic and Analgesic Drugs Market Size by Application
3.3.1 India Antipyretic and Analgesic Drugs Sales in Value, by Application (2018, 2024 & 2034)
3.3.2 India Antipyretic and Analgesic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
3.3.3 India Antipyretic and Analgesic Drugs Average Selling Price (ASP) by Application (2018, 2024 & 2034)
4 Global Antipyretic and Analgesic Drugs Competitor Landscape by Company
4.1 Global Antipyretic and Analgesic Drugs Market Size by Company
4.1.1 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Ranked by Revenue (2024)
4.1.2 Global Antipyretic and Analgesic Drugs Revenue by Manufacturer (2018-2023)
4.1.3 Global Antipyretic and Analgesic Drugs Sales by Manufacturer (2018-2023)
4.1.4 Global Antipyretic and Analgesic Drugs Price by Manufacturer (2018-2023)
4.2 Global Antipyretic and Analgesic Drugs Concentration Ratio (CR)
4.2.1 Antipyretic and Analgesic Drugs Market Concentration Ratio (CR)
4.2.2 Global Top 5 and Top 10 Largest Manufacturers of Antipyretic and Analgesic Drugs in 2024
4.2.3 Global Antipyretic and Analgesic Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.3 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Base Distribution and Headquarters
4.4 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Product Offered and Application
4.5 Global Key Manufacturers of Antipyretic and Analgesic Drugs, Date of Enter into This Industry
4.6 Manufacturers Mergers & Acquisitions, Expansion Plans
4.7 India Antipyretic and Analgesic Drugs Market Size by Company
4.7.1 Key Players of Antipyretic and Analgesic Drugs in India, Ranked by Revenue (2024)
4.7.2 India Antipyretic and Analgesic Drugs Revenue by Players (2018-2023)
4.7.3 India Antipyretic and Analgesic Drugs Sales by Players (2018-2023)
5 Global Antipyretic and Analgesic Drugs Market Size by Region
5.1 Global Antipyretic and Analgesic Drugs Market Size by Region: 2018 VS 2024 VS 2034
5.2 Global Antipyretic and Analgesic Drugs Market Size in Volume by Region (2018-2034)
5.2.1 Global Antipyretic and Analgesic Drugs Sales in Volume by Region: 2018-2023
5.2.2 Global Antipyretic and Analgesic Drugs Sales in Volume Forecast by Region (2024-2034)
5.3 Global Antipyretic and Analgesic Drugs Market Size in Value by Region (2018-2034)
5.3.1 Global Antipyretic and Analgesic Drugs Sales in Value by Region: 2018-2023
5.3.2 Global Antipyretic and Analgesic Drugs Sales in Value by Region: 2024-2034
6 Americas
6.1 Americas Antipyretic and Analgesic Drugs Market Size YoY Growth 2018-2034
6.2 Americas Antipyretic and Analgesic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
6.3 Americas Antipyretic and Analgesic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
6.4 Americas Antipyretic and Analgesic Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
6.4.1 Americas Antipyretic and Analgesic Drugs Sales in Value by Country (2018, 2024 & 2034)
6.4.2 Americas Antipyretic and Analgesic Drugs Sales in Volume by Country (2018, 2024 & 2034)
6.4.3 United States
6.4.4 Canada
6.4.5 Mexico
6.4.6 Brazil
7 EMEA
7.1 EMEA Antipyretic and Analgesic Drugs Market Size YoY Growth 2018-2034
7.2 EMEA Antipyretic and Analgesic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
7.3 EMEA Antipyretic and Analgesic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
7.4 EMEA Antipyretic and Analgesic Drugs Market Facts & Figures by Country (2018, 2024 & 2034)
7.4.1 EMEA Antipyretic and Analgesic Drugs Sales in Value by Country (2018, 2024 & 2034)
7.4.2 EMEA Antipyretic and Analgesic Drugs Sales in Volume by Country (2018, 2024 & 2034)
7.4.3 Europe
7.4.4 Middle East
7.4.5 Africa
8 China
8.1 China Antipyretic and Analgesic Drugs Market Size YoY Growth 2018-2034
8.2 China Antipyretic and Analgesic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
8.3 China Antipyretic and Analgesic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
9 APAC
9.1 APAC Antipyretic and Analgesic Drugs Market Size YoY Growth 2018-2034
9.2 APAC Antipyretic and Analgesic Drugs Sales in Volume, by Type (2018, 2024 & 2034)
9.3 APAC Antipyretic and Analgesic Drugs Sales in Volume, by Application (2018, 2024 & 2034)
9.4 APAC Antipyretic and Analgesic Drugs Market Facts & Figures by Region (2018, 2024 & 2034)
9.4.1 APAC Antipyretic and Analgesic Drugs Sales in Value by Region (2018, 2024 & 2034)
9.4.2 APAC Antipyretic and Analgesic Drugs Sales in Volume by Region (2018, 2024 & 2034)
9.4.3 Japan
9.4.4 South Korea
9.4.5 China Taiwan
9.4.6 Southeast Asia
9.4.7 India
10 Company Profiles
10.1 Mallinckrodt
10.1.1 Mallinckrodt Company Information
10.1.2 Mallinckrodt Description and Business Overview
10.1.3 Mallinckrodt Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Mallinckrodt Antipyretic and Analgesic Drugs Products Offered
10.1.5 Mallinckrodt Recent Development
10.2 SKPL
10.2.1 SKPL Company Information
10.2.2 SKPL Description and Business Overview
10.2.3 SKPL Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.2.4 SKPL Antipyretic and Analgesic Drugs Products Offered
10.2.5 SKPL Recent Development
10.3 Pfizer
10.3.1 Pfizer Company Information
10.3.2 Pfizer Description and Business Overview
10.3.3 Pfizer Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.3.4 Pfizer Antipyretic and Analgesic Drugs Products Offered
10.3.5 Pfizer Recent Development
10.4 Sanofi
10.4.1 Sanofi Company Information
10.4.2 Sanofi Description and Business Overview
10.4.3 Sanofi Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Sanofi Antipyretic and Analgesic Drugs Products Offered
10.4.5 Sanofi Recent Development
10.5 Bayer
10.5.1 Bayer Company Information
10.5.2 Bayer Description and Business Overview
10.5.3 Bayer Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Bayer Antipyretic and Analgesic Drugs Products Offered
10.5.5 Bayer Recent Development
10.6 China National Medicines Guorui Pharmaceutical
10.6.1 China National Medicines Guorui Pharmaceutical Company Information
10.6.2 China National Medicines Guorui Pharmaceutical Description and Business Overview
10.6.3 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.6.4 China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.6.5 China National Medicines Guorui Pharmaceutical Recent Development
10.7 Baotai Pharmaceutical
10.7.1 Baotai Pharmaceutical Company Information
10.7.2 Baotai Pharmaceutical Description and Business Overview
10.7.3 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.7.4 Baotai Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.7.5 Baotai Pharmaceutical Recent Development
10.8 Huaan Pharmaceutical
10.8.1 Huaan Pharmaceutical Company Information
10.8.2 Huaan Pharmaceutical Description and Business Overview
10.8.3 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.8.4 Huaan Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.8.5 Huaan Pharmaceutical Recent Development
10.9 Yuanhe Pharmaceutical
10.9.1 Yuanhe Pharmaceutical Company Information
10.9.2 Yuanhe Pharmaceutical Description and Business Overview
10.9.3 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.9.4 Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.9.5 Yuanhe Pharmaceutical Recent Development
10.10 Heping Pharmaceutical
10.10.1 Heping Pharmaceutical Company Information
10.10.2 Heping Pharmaceutical Description and Business Overview
10.10.3 Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.10.4 Heping Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.10.5 Heping Pharmaceutical Recent Development
10.11 Hongxing Pharmaceutical
10.11.1 Hongxing Pharmaceutical Company Information
10.11.2 Hongxing Pharmaceutical Description and Business Overview
10.11.3 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.11.4 Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.11.5 Hongxing Pharmaceutical Recent Development
10.12 Xinhui Pharmaceutical
10.12.1 Xinhui Pharmaceutical Company Information
10.12.2 Xinhui Pharmaceutical Description and Business Overview
10.12.3 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.12.4 Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.12.5 Xinhui Pharmaceutical Recent Development
10.13 Dingchang Pharmaceutical
10.13.1 Dingchang Pharmaceutical Company Information
10.13.2 Dingchang Pharmaceutical Description and Business Overview
10.13.3 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.13.4 Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.13.5 Dingchang Pharmaceutical Recent Development
10.14 Topfond Pharmaceutical
10.14.1 Topfond Pharmaceutical Company Information
10.14.2 Topfond Pharmaceutical Description and Business Overview
10.14.3 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.14.4 Topfond Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.14.5 Topfond Pharmaceutical Recent Development
10.15 Taile Pharmaceutical
10.15.1 Taile Pharmaceutical Company Information
10.15.2 Taile Pharmaceutical Description and Business Overview
10.15.3 Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.15.4 Taile Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.15.5 Taile Pharmaceutical Recent Development
10.16 Kys Pharm
10.16.1 Kys Pharm Company Information
10.16.2 Kys Pharm Description and Business Overview
10.16.3 Kys Pharm Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.16.4 Kys Pharm Antipyretic and Analgesic Drugs Products Offered
10.16.5 Kys Pharm Recent Development
10.17 China Resources Double-Crane Pharmaceutical
10.17.1 China Resources Double-Crane Pharmaceutical Company Information
10.17.2 China Resources Double-Crane Pharmaceutical Description and Business Overview
10.17.3 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales, Revenue and Gross Margin (2018-2023)
10.17.4 China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Products Offered
10.17.5 China Resources Double-Crane Pharmaceutical Recent Development
11 Industry Chain and Sales Channels Analysis
11.1 Antipyretic and Analgesic Drugs Industry Chain Analysis
11.2 Antipyretic and Analgesic Drugs Key Raw Materials
11.2.1 Key Raw Materials
11.2.2 Raw Materials Key Suppliers
11.3 Antipyretic and Analgesic Drugs Production Mode & Process
11.4 Antipyretic and Analgesic Drugs Sales and Marketing
11.4.1 Antipyretic and Analgesic Drugs Sales Channels
11.4.2 Antipyretic and Analgesic Drugs Distributors
11.5 Antipyretic and Analgesic Drugs Customers
12 Research Findings and Conclusion
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer

List of Figure

List of Tables
Table 1. Antipyretic and Analgesic Drugs CAGR in Value, India VS Global, 2018 VS 2024 VS 2034
Table 2. Antipyretic and Analgesic Drugs Market Trends
Table 3. Antipyretic and Analgesic Drugs Market Drivers
Table 4. Antipyretic and Analgesic Drugs Market Challenges
Table 5. Antipyretic and Analgesic Drugs Market Restraints
Table 6. Global Antipyretic and Analgesic Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 7. India Antipyretic and Analgesic Drugs Sales Growth Rate (CAGR) by Type: 2018 VS 2024 VS 2034 (US$ Million)
Table 8. Global Antipyretic and Analgesic Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 9. India Antipyretic and Analgesic Drugs Sales Growth Rate (CAGR) by Application: 2018 VS 2024 VS 2034 (US$ Million)
Table 10. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Ranked by Revenue (2024) & (US$ Million)
Table 11. Global Antipyretic and Analgesic Drugs Revenue by Manufacturer, (US$ Million), 2018-2023
Table 12. Global Antipyretic and Analgesic Drugs Revenue Share by Manufacturer, 2018-2023
Table 13. Global Antipyretic and Analgesic Drugs Sales by Manufacturer, (K Units), 2018-2023
Table 14. Global Antipyretic and Analgesic Drugs Sales Share by Manufacturer, 2018-2023
Table 15. Global Antipyretic and Analgesic Drugs Price by Manufacturer (2018-2023) & (US$/Unit)
Table 16. Global Antipyretic and Analgesic Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Global Antipyretic and Analgesic Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Antipyretic and Analgesic Drugs as of 2024)
Table 18. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Manufacturing Base Distribution and Headquarters
Table 19. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Product Offered and Application
Table 20. Global Key Manufacturers of Antipyretic and Analgesic Drugs, Date of Enter into This Industry
Table 21. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 22. Key Players of Antipyretic and Analgesic Drugs in India, Ranked by Revenue (2024) & (US$ million)
Table 23. India Antipyretic and Analgesic Drugs Revenue by Players, (US$ Million), (2018-2023)
Table 24. India Antipyretic and Analgesic Drugs Revenue Share by Players, (2018-2023)
Table 25. India Antipyretic and Analgesic Drugs Sales by Players, (K Units), (2018-2023)
Table 26. India Antipyretic and Analgesic Drugs Sales Share by Players, (2018-2023)
Table 27. Global Antipyretic and Analgesic Drugs Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2024 VS 2034
Table 28. Global Antipyretic and Analgesic Drugs Sales in Volume by Region (2018-2023) & (K Units)
Table 29. Global Antipyretic and Analgesic Drugs Sales in Volume Forecast by Region (2024-2034) & (K Units)
Table 30. Global Antipyretic and Analgesic Drugs Sales in Value by Region (2018-2023) & (US$ Million)
Table 31. Global Antipyretic and Analgesic Drugs Sales in Value Forecast by Region (2024-2034) & (US$ Million)
Table 32. Americas Antipyretic and Analgesic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 33. Americas Antipyretic and Analgesic Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 34. Americas Antipyretic and Analgesic Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 35. Americas Antipyretic and Analgesic Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 36. Americas Antipyretic and Analgesic Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 37. EMEA Antipyretic and Analgesic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 38. EMEA Antipyretic and Analgesic Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 39. EMEA Antipyretic and Analgesic Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 40. EMEA Antipyretic and Analgesic Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 41. EMEA Antipyretic and Analgesic Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 42. APAC Antipyretic and Analgesic Drugs Market Size Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2024 VS 2034
Table 43. APAC Antipyretic and Analgesic Drugs Sales in Value by Country (2018-2023) & (US$ Million)
Table 44. APAC Antipyretic and Analgesic Drugs Sales in Value by Country (2024-2034) & (US$ Million)
Table 45. APAC Antipyretic and Analgesic Drugs Sales in Volume by Country (2018-2023) & (K Units)
Table 46. APAC Antipyretic and Analgesic Drugs Sales in Volume by Country (2024-2034) & (K Units)
Table 47. Mallinckrodt Company Information
Table 48. Mallinckrodt Description and Business Overview
Table 49. Mallinckrodt Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 50. Mallinckrodt Antipyretic and Analgesic Drugs Product
Table 51. Mallinckrodt Recent Development
Table 52. SKPL Company Information
Table 53. SKPL Description and Business Overview
Table 54. SKPL Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 55. SKPL Antipyretic and Analgesic Drugs Product
Table 56. SKPL Recent Development
Table 57. Pfizer Company Information
Table 58. Pfizer Description and Business Overview
Table 59. Pfizer Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 60. Pfizer Antipyretic and Analgesic Drugs Product
Table 61. Pfizer Recent Development
Table 62. Sanofi Company Information
Table 63. Sanofi Description and Business Overview
Table 64. Sanofi Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 65. Sanofi Antipyretic and Analgesic Drugs Product
Table 66. Sanofi Recent Development
Table 67. Bayer Company Information
Table 68. Bayer Description and Business Overview
Table 69. Bayer Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 70. Bayer Antipyretic and Analgesic Drugs Product
Table 71. Bayer Recent Development
Table 72. China National Medicines Guorui Pharmaceutical Company Information
Table 73. China National Medicines Guorui Pharmaceutical Description and Business Overview
Table 74. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 75. China National Medicines Guorui Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 76. China National Medicines Guorui Pharmaceutical Recent Development
Table 77. Baotai Pharmaceutical Company Information
Table 78. Baotai Pharmaceutical Description and Business Overview
Table 79. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 80. Baotai Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 81. Baotai Pharmaceutical Recent Development
Table 82. Huaan Pharmaceutical Company Information
Table 83. Huaan Pharmaceutical Description and Business Overview
Table 84. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 85. Huaan Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 86. Huaan Pharmaceutical Recent Development
Table 87. Yuanhe Pharmaceutical Company Information
Table 88. Yuanhe Pharmaceutical Description and Business Overview
Table 89. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 90. Yuanhe Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 91. Yuanhe Pharmaceutical Recent Development
Table 92. Heping Pharmaceutical Company Information
Table 93. Heping Pharmaceutical Description and Business Overview
Table 94. Heping Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 95. Heping Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 96. Heping Pharmaceutical Recent Development
Table 97. Hongxing Pharmaceutical Company Information
Table 98. Hongxing Pharmaceutical Description and Business Overview
Table 99. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 100. Hongxing Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 101. Hongxing Pharmaceutical Recent Development
Table 102. Xinhui Pharmaceutical Company Information
Table 103. Xinhui Pharmaceutical Description and Business Overview
Table 104. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 105. Xinhui Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 106. Xinhui Pharmaceutical Recent Development
Table 107. Dingchang Pharmaceutical Company Information
Table 108. Dingchang Pharmaceutical Description and Business Overview
Table 109. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 110. Dingchang Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 111. Dingchang Pharmaceutical Recent Development
Table 112. Topfond Pharmaceutical Company Information
Table 113. Topfond Pharmaceutical Description and Business Overview
Table 114. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 115. Topfond Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 116. Topfond Pharmaceutical Recent Development
Table 117. Taile Pharmaceutical Company Information
Table 118. Taile Pharmaceutical Description and Business Overview
Table 119. Taile Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 120. Taile Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 121. Taile Pharmaceutical Recent Development
Table 122. Kys Pharm Company Information
Table 123. Kys Pharm Description and Business Overview
Table 124. Kys Pharm Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 125. Kys Pharm Antipyretic and Analgesic Drugs Product
Table 126. Kys Pharm Recent Development
Table 127. China Resources Double-Crane Pharmaceutical Company Information
Table 128. China Resources Double-Crane Pharmaceutical Description and Business Overview
Table 129. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 130. China Resources Double-Crane Pharmaceutical Antipyretic and Analgesic Drugs Product
Table 131. China Resources Double-Crane Pharmaceutical Recent Development
Table 132. Key Raw Materials Lists
Table 133. Raw Materials Key Suppliers Lists
Table 134. Antipyretic and Analgesic Drugs Customers List
Table 135. Antipyretic and Analgesic Drugs Distributors List
Table 136. Research Programs/Design for This Report
Table 137. Key Data Information from Secondary Sources
Table 138. Key Data Information from Primary Sources
List of Figures
Figure 1. Antipyretic and Analgesic Drugs Product Picture
Figure 2. Global Antipyretic and Analgesic Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 3. Global Antipyretic and Analgesic Drugs Market Size 2018-2034 (US$ Million)
Figure 4. Global Antipyretic and Analgesic Drugs Sales 2018-2034 (K Units)
Figure 5. India Antipyretic and Analgesic Drugs Revenue, (US$ Million), 2018 VS 2024 VS 2034
Figure 6. India Antipyretic and Analgesic Drugs Market Size 2018-2034 (US$ Million)
Figure 7. India Antipyretic and Analgesic Drugs Sales 2018-2034 (K Units)
Figure 8. India Antipyretic and Analgesic Drugs Market Share in Global, in Value (US$ Million) 2018-2034
Figure 9. India Antipyretic and Analgesic Drugs Market Share in Global, in Volume (K Units) 2018-2034
Figure 10. Antipyretic and Analgesic Drugs Report Years Considered
Figure 11. Product Picture of Ibuprofen
Figure 12. Product Picture of Paracetamol
Figure 13. Product Picture of Analgin
Figure 14. Product Picture of Naproxen
Figure 15. Product Picture of Aspirin
Figure 16. Product Picture of Others
Figure 17. Global Antipyretic and Analgesic Drugs Market Share by Type in 2024 & 2034
Figure 18. Global Antipyretic and Analgesic Drugs Sales in Value by Type (2018-2034) & (US$ Million)
Figure 19. Global Antipyretic and Analgesic Drugs Sales Market Share in Value by Type (2018-2034)
Figure 20. Global Antipyretic and Analgesic Drugs Sales by Type (2018-2034) & (K Units)
Figure 21. Global Antipyretic and Analgesic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 22. Global Antipyretic and Analgesic Drugs Price by Type (2018-2034) & (US$/Unit)
Figure 23. India Antipyretic and Analgesic Drugs Market Share by Type in 2024 & 2034
Figure 24. India Antipyretic and Analgesic Drugs Sales in Value by Type (2018-2034) & (US$ Million)
Figure 25. India Antipyretic and Analgesic Drugs Sales Market Share in Value by Type (2018-2034)
Figure 26. India Antipyretic and Analgesic Drugs Sales by Type (2018-2034) & (K Units)
Figure 27. India Antipyretic and Analgesic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 28. India Antipyretic and Analgesic Drugs Price by Type (2018-2034) & (US$/Unit)
Figure 29. Product Picture of Hospital
Figure 30. Product Picture of Clinic
Figure 31. Global Antipyretic and Analgesic Drugs Market Share by Application in 2024 & 2034
Figure 32. Global Antipyretic and Analgesic Drugs Sales in Value by Application (2018-2034) & (US$ Million)
Figure 33. Global Antipyretic and Analgesic Drugs Sales Market Share in Value by Application (2018-2034)
Figure 34. Global Antipyretic and Analgesic Drugs Sales by Application (2018-2034) & (K Units)
Figure 35. Global Antipyretic and Analgesic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 36. Global Antipyretic and Analgesic Drugs Price by Application (2018-2034) & (US$/Unit)
Figure 37. India Antipyretic and Analgesic Drugs Market Share by Application in 2024 & 2034
Figure 38. India Antipyretic and Analgesic Drugs Sales in Value by Application (2018-2034) & (US$ Million)
Figure 39. India Antipyretic and Analgesic Drugs Sales Market Share in Value by Application (2018-2034)
Figure 40. India Antipyretic and Analgesic Drugs Sales by Application (2018-2034) & (K Units)
Figure 41. India Antipyretic and Analgesic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 42. India Antipyretic and Analgesic Drugs Price by Application (2018-2034) & (US$/Unit)
Figure 43. Americas Antipyretic and Analgesic Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 44. Americas Antipyretic and Analgesic Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 45. Americas Antipyretic and Analgesic Drugs Sales by Type (2018-2034) & (K Units)
Figure 46. Americas Antipyretic and Analgesic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 47. Americas Antipyretic and Analgesic Drugs Sales by Application (2018-2034) & (K Units)
Figure 48. Americas Antipyretic and Analgesic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 49. United States Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 50. Canada Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 51. Mexico Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 52. Brazil Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 53. EMEA Antipyretic and Analgesic Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 54. EMEA Antipyretic and Analgesic Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 55. EMEA Antipyretic and Analgesic Drugs Sales by Type (2018-2034) & (K Units)
Figure 56. EMEA Antipyretic and Analgesic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 57. EMEA Antipyretic and Analgesic Drugs Sales by Application (2018-2034) & (K Units)
Figure 58. EMEA Antipyretic and Analgesic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 59. Europe Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 60. Middle East Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 61. Africa Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 62. China Antipyretic and Analgesic Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 63. China Antipyretic and Analgesic Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 64. China Antipyretic and Analgesic Drugs Sales by Type (2018-2034) & (K Units)
Figure 65. China Antipyretic and Analgesic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 66. China Antipyretic and Analgesic Drugs Sales by Application (2018-2034) & (K Units)
Figure 67. China Antipyretic and Analgesic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 68. APAC Antipyretic and Analgesic Drugs Sales in Volume Growth Rate 2018-2034 (K Units)
Figure 69. APAC Antipyretic and Analgesic Drugs Sales in Value Growth Rate 2018-2034 (US$ Million)
Figure 70. APAC Antipyretic and Analgesic Drugs Sales by Type (2018-2034) & (K Units)
Figure 71. APAC Antipyretic and Analgesic Drugs Sales Market Share in Volume by Type (2018-2034)
Figure 72. APAC Antipyretic and Analgesic Drugs Sales by Application (2018-2034) & (K Units)
Figure 73. APAC Antipyretic and Analgesic Drugs Sales Market Share in Volume by Application (2018-2034)
Figure 74. Japan Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 75. South Korea Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 76. China Taiwan Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 77. Southeast Asia Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 78. India Antipyretic and Analgesic Drugs Sales in Value Growth Rate (2018-2034) & (US$ Million)
Figure 79. Antipyretic and Analgesic Drugs Value Chain
Figure 80. Antipyretic and Analgesic Drugs Production Process
Figure 81. Channels of Distribution
Figure 82. Distributors Profiles
Figure 83. Bottom-up and Top-down Approaches for This Report
Figure 84. Data Triangulation
Figure 85. Key Executives Interviewed